These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 2459612)
41. Use of antibodies in the study of protein structure and function in lung diseases. Miller EJ; Cohen AB Am J Physiol; 1991 Feb; 260(2 Pt 1):L1-12. PubMed ID: 1705102 [TBL] [Abstract][Full Text] [Related]
42. Structure of the Malpha2-3 toxin alpha antibody-antigen complex: combination of modelling with functional mapping experimental results. Tenette-Souaille C; Smith JC Protein Eng; 2000 May; 13(5):345-51. PubMed ID: 10835108 [TBL] [Abstract][Full Text] [Related]
43. Conformational requirements for molecular recognition of acetylcholine receptor main immunogenic region (MIR) analogues by monoclonal anti-MIR antibody: a two-dimensional nuclear magnetic resonance and molecular dynamics approach. Tsikaris V; Detsikas E; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ; Marraud M; Cung MT Biopolymers; 1993 Jul; 33(7):1123-34. PubMed ID: 8343589 [TBL] [Abstract][Full Text] [Related]
44. The antigenic structure of the acetylcholine receptor from Torpedo californica. Gullick WJ; Lindstrom JM J Cell Biochem; 1982; 19(3):223-30. PubMed ID: 6185511 [TBL] [Abstract][Full Text] [Related]
45. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162. Oshima M; Atassi MZ J Immunol; 1995 May; 154(10):5245-54. PubMed ID: 7537303 [TBL] [Abstract][Full Text] [Related]
46. Mapping the mAb 383C epitope to alpha 2(187-199) of the Torpedo acetylcholine receptor on the three-dimensional model. Fairclough RH; Twaddle GM; Gudipati E; Stone RJ; Richman DP; Burkwall DA; Josephs R J Mol Biol; 1998 Sep; 282(2):301-15. PubMed ID: 9735289 [TBL] [Abstract][Full Text] [Related]
47. Identification of epitopes within a highly immunogenic region of acetylcholine receptor by a phage epitope library. Barchan D; Balass M; Souroujon MC; Katchalski-Katzir E; Fuchs S J Immunol; 1995 Nov; 155(9):4264-9. PubMed ID: 7594584 [TBL] [Abstract][Full Text] [Related]
48. Determination of antibody binding sites on the three-dimensional and primary structure of acetylcholine receptor. Tzartos SJ; Kordossi A; Walgrave SL; Kokla A; Conti-Tronconi BM Monogr Allergy; 1988; 25():20-32. PubMed ID: 2459612 [No Abstract] [Full Text] [Related]
49. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Atassi MZ; Oshima M; Deitiker P Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597 [TBL] [Abstract][Full Text] [Related]
51. Antibody combining sites: how much of the antibody repertoire are we seeing? How does it influence our understanding of the structural and genetic basis of antibody complimentarity? Kabat EA Adv Exp Med Biol; 1988; 228():1-45. PubMed ID: 3051914 [No Abstract] [Full Text] [Related]